Oncology Consortium

Impactful Education Through Innovative Engagement

roy.berger@theoncologyconsortium.com | (516) 729-0303
Service Hours

Bio-statistics Oncology Consortium

Gosford Sawyerr is currently an independent statistical consultant available to clients in the biopharmaceutical and medical device industry to assist with study design, statistical analysis and reporting, and to provide statistical counsel to interested persons and/or organizations. Gosford graduated with first class honors at the University of Ghana, Legon. After lecturing for two years at Legon, he embarked on graduate studies in statistics at the University of Rochester in update New York where he obtained his master’s in statistics. His thesis work examining aspects of complete monotonicity in server systems with random order of service discipline was under the supervision of the late Professor Julian Keilson. He has lectured in statistics and mathematics for 18 years at the University of Ghana, the University of Rochester, Monroe Community College, and Rochester Institute of Technology. Since 1986 he has been working in the pharmaceutical industry as a statistician, with varying levels of responsibility. He has worked at Fisons Pharmaceuticals (now Sanofi Aventis), GlaxoSmithKline, Medtronic Inc, and Purdue Pharma. Since June 2012 he has been a consultant statistician on assignment with different clients. He has worked on drugs/devices/biologics in the following therapeutic areas: cardiovascular, oncology, respiratory, opioid analgesics, antiarrhythmia, HIV, antivirals.

Gosford has coauthored peer reviewed journal articles and publications at medical and statistical conferences, and has organized many sessions on current issues at statistical conferences, leading to receipt of an award from the FDA for superior teamwork in the development of an educational program.

Gosford’s current research interests include designing efficient submission trials and the implementation of methods to handle missing data. He is passionate about teaching statistics to nonstatistcians and statisticians alike.

Oncology Consortium | All Rights Reserved 2012-2017
Back to Top